Literature DB >> 10363725

HLA and susceptibility to cervical neoplasia.

E J Krul1, R F Schipper, G M Schreuder, G J Fleuren, G G Kenter, C J Melief.   

Abstract

The association between cervical neoplasia and certain HLA phenotypes observed in different studies has not been consistent. By serological typing, the association between HLA antigens, cervical carcinoma and cervical intraepithelial neoplasia (CIN) was studied in a group of 172 and 116 patients, respectively. We demonstrated an increased frequency of B63 in patients with HPV types other than HPV 16 or 18, and B55 in patients that were negative for all HPV types. The association between cervical carcinoma and DQ3, described in various populations, was not observed in the present study. However, we confirmed other previously observed associations between cervical cancer and class II antigens, i.e., a positive correlation with DR15 irrespective of the HPV status, with DR3 in patients harboring HPV types other than HPV 16 or 18, and with DR11 among HPV 16 positive patients. In contrast, a negative correlation between DR13 and HPV positive cervical cancer was observed which suggests protection of this antigen against HPV-associated cervical cancer. A slight increase of DR15 and DQ4 antigens was observed in CIN patients, suggesting that these specific HLA antigens may be important in determining the risk of CIN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363725     DOI: 10.1016/s0198-8859(98)00127-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  HLA and KIR Associations of Cervical Neoplasia.

Authors:  Xiao Bao; Aimee L Hanson; Margaret M Madeleine; Sophia S Wang; Stephen M Schwartz; Felicity Newell; Ulrika Pettersson-Kymmer; Kari Hemminki; Sven Tiews; Winfried Steinberg; Janet S Rader; Felipe Castro; Mahboobeh Safaeian; Eduardo L Franco; François Coutlée; Claes Ohlsson; Adrian Cortes; Mhairi Marshall; Pamela Mukhopadhyay; Katie Cremin; Lisa G Johnson; Suzanne M Garland; Sepehr N Tabrizi; Nicolas Wentzensen; Freddy Sitas; Cornelia Trimble; Julian Little; Maggie Cruickshank; Ian H Frazer; Allan Hildesheim; Matthew A Brown; Emma L Duncan; Ying Pu Sun; Paul J Leo
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

2.  Brain glioma and human leukocyte antigens (HLA)--is there an association.

Authors:  H K Machulla; F Steinborn; A Schaaf; V Heidecke; N G Rainov
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

3.  Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.

Authors:  I Bourgault Villada; M Moyal Barracco; S Berville; M L Bafounta; C Longvert; V Prémel; P Villefroy; E Jullian; T Clerici; B Paniel; B Maillère; J Choppin; J G Guillet
Journal:  Clin Exp Immunol       Date:  2009-07-30       Impact factor: 4.330

4.  Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis.

Authors:  Malin T Engelmark; Emma L Ivansson; Jessica J Magnusson; Inger M Gustavsson; Per-Ivan Wyöni; Max Ingman; Patrik K E Magnusson; Ulf B Gyllensten
Journal:  Hum Genet       Date:  2008-04-08       Impact factor: 4.132

5.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

6.  HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study.

Authors:  Sofía Bernal-Silva; Julio Granados; Clara Gorodezky; Carmen Aláez; Hilario Flores-Aguilar; Ricardo M Cerda-Flores; Geraldina Guerrero-González; Lezmes D Valdez-Chapa; José Morales-Casas; Juan Francisco González-Guerrero; Hugo A Barrera-Saldaña
Journal:  Infect Agent Cancer       Date:  2013-08-30       Impact factor: 2.965

7.  In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.

Authors:  Orsolya Lőrincz; József Tóth; Levente Molnár; István Miklós; Kata Pántya; Mónika Megyesi; Eszter Somogyi; Zsolt Csiszovszki; Enikő R Tőke
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

8.  Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.

Authors:  Patricia S de Araujo Souza; Paulo C Maciag; Karina B Ribeiro; Maria Luiza Petzl-Erler; Eduardo L Franco; Luisa L Villa
Journal:  BMC Cancer       Date:  2008-08-22       Impact factor: 4.430

9.  Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.

Authors:  Dan Chen; Stefan Enroth; Han Liu; Yang Sun; Huibo Wang; Min Yu; Lian Deng; Shuhua Xu; Ulf Gyllensten
Journal:  Oncotarget       Date:  2016-07-05

10.  Replication of results from a cervical cancer genome-wide association study in Taiwanese women.

Authors:  Yuh-Cheng Yang; Tzu-Yang Chang; Tze-Chien Chen; Wen-Shan Lin; Chiung-Ling Lin; Yann-Jinn Lee
Journal:  Sci Rep       Date:  2018-10-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.